Form D · Hedge Fund
Phase 3 Biotech Fund, LP
Highlands Ranch, CO · CIK 0001806165
Offering snapshot reported Mar 16, 2020 · SEC filing
- Reported sold
- $411K Indefinite offering
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 2, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 16, 2020 | Initial | $410,750 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-362948
Source: Form D, filed Mar 16, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gordon Andringa | Executive |
| A Delaware Limited Liability Company Phase 3 Biotech Fund Gp, Llc | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
51 Falcon Hills Drive
Highlands Ranch, CO, 80126
Highlands Ranch, CO, 80126